Outcomes Following Lung Transplant for COVID-19-Related Complications in the US.

ABSTRACT:

Importance

The COVID-19 pandemic led to the use of lung transplant as a lifesaving therapy for patients with irreversible lung injury. Limited information is currently available regarding the outcomes associated with this treatment modality.

Objective

To describe the outcomes following lung transplant for COVID-19-related acute respiratory distress syndrome or pulmonary fibrosis.

Design, setting, and participants

In this cohort study, lung transplant recipient and donor characteristics and outcomes following lung transplant for COVID-19-related acute respiratory distress syndrome or pulmonary fibrosis were extracted from the US United Network for Organ Sharing database from March 2020 to August 2022 with a median (IQR) follow-up period of 186 (64-359) days in the acut

SUBMITTER: Tasoudis P 

PROVIDER: S-EPMC10433141 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature